Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...

Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...

Motif ? one of the clinical trial technology market's fastest growing companies ? continues contributing to major innovations in how clinical trial patient data are collected, with Chief Scientific ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...

Riad Mishlawi is stepping down from the top role by ‘mutual agreement’ with the firm’s board of directors, it told investors.

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

The Magnum Ice Cream Company, the recent ice cream spin-off from Unilever, rose to the top of the pan-European benchmark, ...

Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...